Cell Based Assay Market: By Product Type (Consumables, Assay Kits, Reagents, Cell growth assay, Reporter gene assay, Immortalized cell lines, Stem cell lines, Primary cell lines, Others), By Application (ADME studies, Basic research, Predictive toxicology, Drug discovery, Other), By End-user (Diagnostic Centres, Hospitals, Biopharmaceutical companies, Contract research organizations) and Geography  

Purchase Option

$ 4400
$ 6600
$ 8900

Cell-Based Assay Market size was valued at USD 17.8 billion in 2023 and is expected to reach USD 27.8 billion by 2030, at a CAGR of 9.1% from 2024- 2030. Cell-based Assay is the analytical technique to determine the different parameters such as biochemical or cellular functions of a living cell. Cell-based Assay is used in the research of new drugs by using functional cells as diagnostic tools. The cell-based Assay is commonly used to measure motility, toxicity, cell proliferation, enzyme activity, and morphology in diagnostics and drug discovery. Cell-based Assay is carried out in several therapeutic areas such as cancer, stem cells, immunology, and others. from Argos Soditic for developing its product portfolio. This report studies market dynamics elaborately to identify the current trends & drivers, future opportunities, and possible challenges to the key stakeholders operating in the market. An increase in the prevalence and incidence of chronic diseases such as cancer, and drug discovery, an increase in government expenditure, and a rise in the adoption of cell-based consumables by various organizations might fuel the cell-based assay market over the forecast period. Moreover, the rise in demand for biological drugs, increase in the preference for toxicity screening in drugs, and reduction of cost associated with drug discovery are expected to boost the market. However, the lack of skilled professionals for conducting the cell-based assays, the high cost of the instruments, and stringent regulatory policies might hinder the growth of the market.

Global Cell Based Assay Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

9.1%

Largest Market

North America

Fastest Growing Market

North America
Cell Based Assay Market Dynamics

The Cell Based Assay market is in developing stage owing to increase in research and development for new drugs. Increase in the prevalence of various cancer diseases and immunological disorders also expected to propel the market growth. Collaborations, acquisitions & merging, and launch of new products are some of the key strategies followed by the players to increase market share. For instance, in November 2016, Axiogenesis collaborated with Metrion Biosciences Ltd to optimise, validate, and commercialize iPSC derived cell-based Assay for the new drug discovery. Investment from various companies for the R&D activities and entry of start-up companies into the market also bolster the market growth.

Key Features of the Reports

  • The report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
  • The report covers in-detail insights about the competitor's overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario

Global Cell Based Assay Market Segmentation

By Product Type
  • Consumables,
  • Assay Kits, Reagents,
  • Cell growth assay,
  • Reporter gene assay,
  • Immortalized cell lines,
  • Stem cell lines,
  • Primary cell lines,
  • Others
By Application
  • ADME studies,
  • Basic research,
  • Predictive toxicology,
  • Drug discovery,
  • Other
By End User
  • Diagnostic Centres,
  • Hospitals,
  • Biopharmaceutical companies,
  • Contract research organizations

Frequently Asked Questions

The cell-based assay market size was valued at USD 17.8 billion in 2023

The cell-based assay market key players are: PerkinElmer Inc. (U.S.) GE Healthcare (UK) ProQinase GmbH (Germany) Danaher Corporation (U.S.) Essen BioScience Inc. (U.S.) Lonza Group (U.S.) Thermo Fisher Scientific Inc. (U.S.) Abenex Capital SA (France) Axiogenesis AG (Germany) Metrion Biosciences Ltd. (U.K.)

The cell-based assay market has been classified into North America, Asia Pacific, Europe, Latin America, Middle East and Africa, and the rest of MEA.

1.Executive Summary
2.Global Cell Based Assay Market Introduction 
2.1.Global Cell Based Assay Market  - Taxonomy
2.2.Global Cell Based Assay Market  - Definitions
2.2.1.Product Type
2.2.2.Application
2.2.3. End User
2.2.4.Region
3.Global Cell Based Assay Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4.Global Cell Based Assay Market Analysis, 2019 - 2023 and Forecast 2024 - 2030
4.1.  Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5.Global Cell Based Assay Market  By Product Type, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
5.1. Consumables,
5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Assay Kits, Reagents,
5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
5.3. Cell growth assay,
5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.3.3. Market Opportunity Analysis 
5.4. Reporter gene assay,
5.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.4.3. Market Opportunity Analysis 
5.5. Immortalized cell lines,
5.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.5.3. Market Opportunity Analysis 
5.6. Stem cell lines,
5.6.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.6.3. Market Opportunity Analysis 
5.7. Primary cell lines,
5.7.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.7.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.7.3. Market Opportunity Analysis 
5.8. Others
5.8.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.8.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.8.3. Market Opportunity Analysis 
6.Global Cell Based Assay Market  By Application, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
6.1. ADME studies,
6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. Basic research,
6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
6.3. Predictive toxicology,
6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.3.3. Market Opportunity Analysis 
6.4. Drug discovery,
6.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.4.3. Market Opportunity Analysis 
6.5. Other
6.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.5.3. Market Opportunity Analysis 
7.Global Cell Based Assay Market  By  End User, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
7.1. Diagnostic Centres,
7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Hospitals,
7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
7.3. Biopharmaceutical companies,
7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.3.3. Market Opportunity Analysis 
7.4. Contract research organizations
7.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.4.3. Market Opportunity Analysis 
8.Global Cell Based Assay Market  By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
8.1. North America
8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.1.3. Market Opportunity Analysis 
8.2. Europe
8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.2.3. Market Opportunity Analysis 
8.3. Asia Pacific (APAC)
8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.3.3. Market Opportunity Analysis 
8.4. Middle East and Africa (MEA)
8.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.4.3. Market Opportunity Analysis 
8.5. Latin America
8.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.5.3. Market Opportunity Analysis 
9.North America Cell Based Assay Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
9.1. Product Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.1.1.Consumables,
9.1.2.Assay Kits, Reagents,
9.1.3.Cell growth assay,
9.1.4.Reporter gene assay,
9.1.5.Immortalized cell lines,
9.1.6.Stem cell lines,
9.1.7.Primary cell lines,
9.1.8.Others
9.2.  Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.2.1.ADME studies,
9.2.2.Basic research,
9.2.3.Predictive toxicology,
9.2.4.Drug discovery,
9.2.5.Other
9.3.   End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.3.1.Diagnostic Centres,
9.3.2.Hospitals,
9.3.3.Biopharmaceutical companies,
9.3.4.Contract research organizations
9.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.4.1.United States of America (USA)
9.4.2.Canada
10.Europe Cell Based Assay Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
10.1. Product Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1.Consumables,
10.1.2.Assay Kits, Reagents,
10.1.3.Cell growth assay,
10.1.4.Reporter gene assay,
10.1.5.Immortalized cell lines,
10.1.6.Stem cell lines,
10.1.7.Primary cell lines,
10.1.8.Others
10.2.  Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.ADME studies,
10.2.2.Basic research,
10.2.3.Predictive toxicology,
10.2.4.Drug discovery,
10.2.5.Other
10.3.   End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1.Diagnostic Centres,
10.3.2.Hospitals,
10.3.3.Biopharmaceutical companies,
10.3.4.Contract research organizations
10.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.4.1.Germany
10.4.2.France
10.4.3.Italy
10.4.4.United Kingdom (UK)
10.4.5.Spain
11.Asia Pacific (APAC) Cell Based Assay Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
11.1. Product Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.Consumables,
11.1.2.Assay Kits, Reagents,
11.1.3.Cell growth assay,
11.1.4.Reporter gene assay,
11.1.5.Immortalized cell lines,
11.1.6.Stem cell lines,
11.1.7.Primary cell lines,
11.1.8.Others
11.2.  Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.ADME studies,
11.2.2.Basic research,
11.2.3.Predictive toxicology,
11.2.4.Drug discovery,
11.2.5.Other
11.3.   End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.Diagnostic Centres,
11.3.2.Hospitals,
11.3.3.Biopharmaceutical companies,
11.3.4.Contract research organizations
11.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.4.1.China
11.4.2.India
11.4.3.Australia and New Zealand (ANZ)
11.4.4.Japan
11.4.5.Rest of APAC
12.Middle East and Africa (MEA) Cell Based Assay Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
12.1. Product Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1.Consumables,
12.1.2.Assay Kits, Reagents,
12.1.3.Cell growth assay,
12.1.4.Reporter gene assay,
12.1.5.Immortalized cell lines,
12.1.6.Stem cell lines,
12.1.7.Primary cell lines,
12.1.8.Others
12.2.  Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.ADME studies,
12.2.2.Basic research,
12.2.3.Predictive toxicology,
12.2.4.Drug discovery,
12.2.5.Other
12.3.   End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.Diagnostic Centres,
12.3.2.Hospitals,
12.3.3.Biopharmaceutical companies,
12.3.4.Contract research organizations
12.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.4.1.GCC Countries
12.4.2.South Africa
12.4.3.Rest of MEA
13.Latin America Cell Based Assay Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
13.1. Product Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.1.1.Consumables,
13.1.2.Assay Kits, Reagents,
13.1.3.Cell growth assay,
13.1.4.Reporter gene assay,
13.1.5.Immortalized cell lines,
13.1.6.Stem cell lines,
13.1.7.Primary cell lines,
13.1.8.Others
13.2.  Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.2.1.ADME studies,
13.2.2.Basic research,
13.2.3.Predictive toxicology,
13.2.4.Drug discovery,
13.2.5.Other
13.3.   End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.3.1.Diagnostic Centres,
13.3.2.Hospitals,
13.3.3.Biopharmaceutical companies,
13.3.4.Contract research organizations
13.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.4.1.Brazil
13.4.2.Mexico
13.4.3.Rest of LA
14. Competition Landscape
14.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
14.2.1.PerkinElmer Inc. (U.S.)
14.2.2.GE Healthcare (U.K)
14.2.3.ProQinase GmbH (Germany)
14.2.4.Danaher Corporation (U.S.)
14.2.5.Essen BioScience Inc. (U.S.)
14.2.6.Lonza Group (U.S.)
14.2.7.Thermo Fisher Scientific Inc. (U.S.)
14.2.8.Abenex Capital SA (France)
14.2.9.Axiogenesis AG (Germany)
14.2.10.Metrion Biosciences Ltd. (U.K.)
15. Research Methodology 
16. Appendix and Abbreviations 
  • PerkinElmer Inc. (U.S.)
  • GE Healthcare (U.K)
  • ProQinase GmbH (Germany)
  • Danaher Corporation (U.S.)
  • Essen BioScience Inc. (U.S.)
  • Lonza Group (U.S.)
  • Thermo Fisher Scientific Inc. (U.S.)
  • Abenex Capital SA (France)
  • Axiogenesis AG (Germany)
  • Metrion Biosciences Ltd. (U.K.)

Adjacent Markets